← All stories
Tech
Owkin signs AI drug discovery deal with Boehringer for cancer, immunology
2 outlets - including Bloomberg and Yahoo - are covering this story. Boehringer Ingelheim GmbH agreed to use Owkin’s artificial-intelligence model to help discover new oncology and immunology medicines.
Covered by 2 outlets
All coverage · 2 articles
Bloomberg Technology
·1h ago
Boehringer Signs Deal for Owkin AI, Joining Astra and Sanofi
Boehringer Ingelheim GmbH agreed to use Owkin’s artificial-intelligence model to help discover new oncology and immunology medicines.
Yahoo Finance News
·2h ago